Arthritis Society Canada
STAR RATINGCi's Star Rating is calculated based on the following independent metrics: |
✔+
FINANCIAL TRANSPARENCY
Audited financial statements for current and previous years available on the charity’s website.
A-
RESULTS REPORTING
Grade based on the charity's public reporting of the work it does and the results it achieves.
n/r
DEMONSTRATED IMPACT
The demonstrated impact per dollar Ci calculates from available program information.
NEED FOR FUNDING
Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.
38%
CENTS TO THE CAUSE
For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 38 cents are available for programs.
My anchor
OVERVIEW
About Arthritis Society Canada:
Arthritis Society Canada is a 3-star charity that is financially transparent. It has an A- results reporting grade, which is above average. Its reserve funds could cover annual program costs for just under two months, which is within Ci’s reasonable range. Its overhead spending is outside of Ci’s reasonable range.
Founded in 1948, Arthritis Society Canada (ASC) funds arthritis research, advocates for policy change, and provides support to improve health among those infected with arthritis. Arthritis is a collection of conditions affecting joints and other tissues. It causes pain, restricts mobility, and diminishes quality of life. Arthritis Society Canada reports that one in five Canadians live with arthritis. There is currently no cure. The charity runs four main programs: Research, Innovation, Advocacy, and Information and Support. In the fiscal year ending March 2025 (F2025), ASC spent $19.1m on its programs. Research represented 37% of program spending and the remaining 63% went to Innovation, Advocacy, and Information and Support.
Research: ASC’s Research focuses on pain relief, osteoarthritis (most common form of arthritis) and inflammatory arthritis. In F2025, ASC had 113 active research projects which included 64 grants, 38 training awards, 10 career developments, and one team grant. These research projects supported 345 researchers: 114 lead researchers, 111 additional trainees, and 120 qualified research personnel.
Innovation: The Innovation program funds social impact projects to uncover ideas to help people living with arthritis. In F2025, ASC reported committing $599,450 to six new Ignite Research Grants. Its Newborn Arthritis Prevention Screening (NAPS) project performed more than 2,000 scans on 1,800 infants.
Advocacy: ASC advocates on behalf of Canadians affected by arthritis to drive policy and raise awareness. In F2025, ASC completed 8,558 advocacy actions, engaged with 73 political and policy representatives, submitted eight pre-budget recommendations, and participated in eight government consultations.
Information and Support: ASC provides evidence-based information, resources, and online tools for people affected by arthritis. In F2025, the charity delivered 5,635 public service announcements to raise awareness. Its website had 1,696,965 visitors, and its newsletter had 126,869 subscribers. Arthritis Talks reached 65,322 people. ASC also operates six camps across Canada for children with arthritis, serving 328 campers in F2025.
My anchor
Results and Impact
In F2025, Arthritis Society Canada’s NAPS project identified 45 cases of hip dysplasia, including 29 that would likely have otherwise gone undetected.
In 2023, Arthritis Society Canada released a report highlighting the problem of wait times arthritis patients face at the hospital. The charity reports 38% of Canadians did not receive their hip or knee joint replacement surgery within the recommended time of six months. The report provided recommendations to provincial and federal governments. The government included many of Arthritis Society’s recommendations in F2022. In March 2022, the federal government added an additional $2 billion to address the backlogs in arthritis surgeries. Nine provinces implemented the charity's recommended GLA:D education and exercise program. 70% of the patients reported significantly improved function.
On its website, ASC published its top ten research advancements for 2023. ASC found an enzyme called Tryptase B which may contribute to osteoarthritis by interfering with the anti-inflammatory and joint-lubricating activities of a protein called PRG4. ASC also found out that small particles made from a type of molecule called polyphosphate can be used to effectively deliver drugs into the cartilage that pads the joints, which was typically a hard-to-reach area for drugs. To learn about the other advancements made in 2023-2024, go through the resources Charity Intelligence provides in the “Learn More” section at the bottom of the webpage.
While Ci highlights these key results, they may not be a complete representation of Arthritis Society Canada’s results and impact. This charity is not yet rated on impact (n/r).
My anchor
Finances
Arthritis Society Canada received $20.1m in donations in F2025, which is 68% of total revenue. It also received $5.9m in government funding, representing 20% of total revenue.
In F2025, ASC spent 19.1m on programs and grants, accounting for 65% of total revenue. The charity ran a deficit of $3.1m which was more than offset by the sale of property of $5.1m.
Fundraising costs were $9.8m, which is 49% of donations, and administrative costs were $3.8m, which is 13% of revenue (excluding investment income). Total overhead spending was 62%, meaning that for every dollar donated, 38 cents are available to go to the cause. This is outside of Ci’s reasonable range, which suggests 65-95 cents per dollar. The charity has been outside the reasonable range since 2013.
At the end of F2025, ASC had $5.4m in reserve funds (cash and investments), including $2.4m of donor-endowed funds. Excluding donor-endowed funds, its reserves could cover annual program costs for just under two months, which is within Ci’s reasonable range.
ASC uses external fundraisers. In F2025, ASC paid $718k to external fundraisers to raise $1.3m, meaning the cost to raise a dollar via external fundraisers is 57 cents. It is likely more efficient to donate directly to the charity.
Comments and corrections may be forthcoming. Profile updated on July 20, 2026 by Ava Anderson.
Financial Review
Fiscal year ending March
|
2025 | 2024 | 2023 |
|---|---|---|---|
| Administrative costs as % of revenues | 13.0% | 13.5% | 12.5% |
| Fundraising costs as % of donations | 48.7% | 44.6% | 39.6% |
| Total overhead spending | 61.6% | 58.0% | 52.1% |
| Program cost coverage (%) | 15.7% | 3.0% | 32.3% |
Summary Financial StatementsAll figures in $000s |
2025 | 2024 | 2023 |
|---|---|---|---|
| Donations | 20,078 | 21,052 | 21,108 |
| Government funding | 5,931 | 7,356 | 5,743 |
| Investment income | 272 | 388 | 1,037 |
| Other income | 3,303 | (911) | 97 |
| Total revenues | 29,584 | 27,886 | 27,986 |
| Program costs | 11,601 | 11,752 | 10,668 |
| Grants | 7,504 | 6,565 | 6,773 |
| Administrative costs | 3,811 | 3,702 | 3,360 |
| Fundraising costs | 9,767 | 9,380 | 8,359 |
| Total spending | 32,683 | 31,399 | 29,160 |
| Cash flow from operations | (3,099) | (3,513) | (1,175) |
| Capital spending | (4,713) | 741 | 521 |
| Funding reserves | 5,372 | 2,924 | 7,971 |
Note: DEFERRED DONATIONS: To report on a cash-basis, Ci adjusts for deferred contributions. This affected total revenues by $1.7m in F2025, ($2.7m) in F2024, and ($1.0m) in F2023. Ci removed these deferred contributions from Other Revenue because it was unclear if they were donations or governmental funding. ENDOWMENT CONTRIBUTIONS: Ci adjusted for endowment contributions impacting total revenues by ($4k) in F2025, ($5k) in F2024, and $13k in F2023. RESEARCH AWARDS PAYABLE: Ci adjusted for research awards payable affecting grants by $473k in F2025, $7k in F2024, and $536k in F2023. AMORTIZATION: ASC did not separately report amortization on its income statement. Ci removed amortization from program, administrative, and fundraising costs on a pro-rata basis.
Salary Information
$350k + |
1 |
$300k - $350k |
2 |
$250k - $300k |
1 |
$200k - $250k |
3 |
$160k - $200k |
3 |
$120k - $160k |
0 |
$80k - $120k |
0 |
$40k - $80k |
0 |
< $40k |
0 |
Information from most recent CRA Charities Directorate filings for F2025



My anchor
Comments & Contact
Comments added by the Charity:
Learn More (posted by Ci):
ASC 2023-2024 Annual Report
ASC Top 10 Research Advancements of 2023
Charity Contact
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 416.979.7228